Introducing
Your new presentation assistant.
Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.
Trending searches
Baxter International &
Northfield Laboratories
1) Launch Oxyglobin first, then launch Hemopure whenever it gets approved (IPO 1 YR after Oxyglobin launch)
2) Wait to launch Hemopure and shelf Oxyglobin for the time being (IPO 1 YR after launching both).
3) Launch Oxyglobin first, then when Hemopure gets approved cut Oxyglobin and only sell 1 product (IPO when Oxyglobin is strong).
Key Aspects:
-Break-Even
-2 Markets
-Beneficial even without FDA
-Innovator in product category
Decision Making Process
Value Creation
Changing Market Outlook
Assumptions & FDA